Clinical Trial Update: Safety and Efficacy Study of Interferon Gamma-1b in Hepatitis C Patients With Liver Fibrosis or Cirrhosis [Phase 2]

View source ↗

Summary

A Phase 2 trial assessed the safety and efficacy of Interferon Gamma-1b in hepatitis C patients with liver fibrosis or cirrhosis. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis
• Hepatitis C
• Liver Fibrosis

Drugs mentioned

• Interferon-gamma 1b (interferon gamma-1b)

Snippet

Sponsor: InterMune | Conditions: Liver Fibrosis, Cirrhosis | Phase 2 | Status: COMPLETED